Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62008TA0477

Case T-477/08: Judgment of the General Court of 4 March 2010 — Mundipharma v OHIM — ALK-Abelló (AVANZALENE) (Community trade mark — Opposition proceedings — Application for the Community word mark AVANZALENE — Earlier Community word mark AVANZ — Likelihood of confusion — Similarity of the signs — Article 8(1)(b) of Regulation (EC) No 40/94 (now Article 8(1)(b) of Regulation (EC) No 207/2009))

SL C 113, 1.5.2010, p. 42–42 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

1.5.2010   

EN

Official Journal of the European Union

C 113/42


Judgment of the General Court of 4 March 2010 — Mundipharma v OHIM — ALK-Abelló (AVANZALENE)

(Case T-477/08) (1)

(Community trade mark - Opposition proceedings - Application for the Community word mark AVANZALENE - Earlier Community word mark AVANZ - Likelihood of confusion - Similarity of the signs - Article 8(1)(b) of Regulation (EC) No 40/94 (now Article 8(1)(b) of Regulation (EC) No 207/2009))

2010/C 113/67

Language of the case: English

Parties

Applicant: Mundipharma AG (Basle, Switzerland) (represented by: F. Nielsen, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: A. Folliard Monguiral, Agent)

Other party to the proceedings before the Board of Appeal of OHIM intervening before the General Court: ALK-Abelló A/S (Hørsholm, Denmark) (represented by: S. Palomäki Arnesen, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 28 August 2008 (Case R 1694/2007-4), relating to opposition proceedings between ALK-Abelló A/S and Mundipharma AG.

Operative part of the judgment

The Court:

1.

Dismisses the action.

2.

Orders Mundipharma AG to pay the costs, except those incurred by ALK-Abelló A/S.

3.

Orders ALK-Abelló to bear its own costs.


(1)  OJ C 6, 10.1.2009.


Top